Takayuki Suyama
Nagasaki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 23, 2025
Clinical features of Mycobacterium abscessus complex and Mycobacterium kansasii pulmonary disease in Kyushu, Japan.
Journal: Respiratory investigation
Published: September 07, 2025
Phase II study of ramucirumab and docetaxel for previously platinum-treated patients with non-small cell lung cancer and malignant pleural effusion (PLEURAM study).
Journal: Translational lung cancer research
Published: June 15, 2024
Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-disease small cell lung cancer: protocol of ACIST study.
Journal: Thoracic cancer
Published: May 05, 2022
Proportion of biopsy specimens containing a tumor when compared to all biopsy specimens by transbronchial biopsy.
Journal: Lung cancer management
Published: January 13, 2022
Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor.
Journal: Journal of clinical medicine
Published: August 04, 2021
Successful treatment with nivolumab for lung cancer with low expression of PD-L1 and prominent tumor-infiltrating B cells and immunoglobulin G.
Journal: Thoracic cancer
Published: March 13, 2018
Last Updated: 09/26/2026